Stepan Esagian/X
Feb 16, 2025, 21:51
Stepan Esagian: Our findings on cytoreductive nephrectomy utilization trends at ASCO GU25
Stepan Esagian, Hematology/Oncology Fellow at MD Anderson Cancer Center, shared a post on X:
“Excited to present our findings on cytoreductive nephrectomy utilization trends at ASCO GU25! Stop by Poster Board D15 to explore the impact of newer mRCC systemic therapies and socioeconomic determinants on current practice patterns!”
Dimitrios Makrakis, Internal Medicine Resident at Albert Einstein College of Medicine, shared this post, adding:
“Excited to see our work with Stepan Esagian and Pavlos Msaouel being featured in ASCO GU25 among many others! Interesting trend of declining CN rates even before CARMENA.”
More posts featuring Stepan Esagian and Dimitrios Makrakis.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 20, 2025, 11:19
Feb 20, 2025, 11:13
Feb 20, 2025, 11:08
Feb 20, 2025, 11:00
Feb 20, 2025, 10:52
Feb 20, 2025, 10:45